Bladder Cancer
Investigators at University of Montreal Discuss Research in Bladder Cancer
Published in Cancer Weekly, March 20th, 2012
2012 MAR 20 -- In this recent study, researchers in Montreal, Canada conducted a study "To employ decision curve analysis to determine the impact of nuclear matrix protein 22 (NMP22) on clinical decision making in the detection of bladder cancer using data from a prospective trial. The study included 1303 patients at risk for bladder cancer who underwent cystoscopy, urine cytology and measurement of urinary NMP22 levels."
"We constructed several prediction models to estimate risk of bladder cancer. The base model was generated using patient characteristics (age, gender, race, smoking and haematuria); cytology and NMP22 were added to the base model to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2012-03-20)
More Articles from Cancer Weekly
- Colon Cancer
American College of Physicians releases new colorectal cancer screening guidance statement - Bladder Cancer
Data on Bladder Cancer Published by Researchers at University of Los Andes - Carcinomas
Data on Carcinomas Described by Researchers at Dalian Medical University - Gastric Cancer
Data on Gastric Cancer Published by Researchers at National Institute for Health Development - Head and Neck Cancer
Data on Head and Neck Cancer Described by Researchers at University of Fukui - Plastic Surgery
Data on Plastic Surgery Reported by Researchers at Memorial Sloan-Kettering Cancer Center - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
